MLN3126, with the CAS number 628300-71-0, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in oncology. It functions as a selective inhibitor of specific protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth, proliferation, and survival. The compound is characterized by its ability to modulate these pathways, potentially leading to the inhibition of tumor growth and the induction of apoptosis in cancer cells. In terms of its chemical properties, MLN3126 exhibits a defined molecular structure that contributes to its biological activity, although specific details regarding its solubility, stability, and pharmacokinetics would depend on the formulation and context of use. As with many investigational drugs, ongoing research is essential to fully elucidate its efficacy, safety profile, and mechanism of action in clinical settings.

MLN3126

628300-71-0: MLN3126, with the CAS number 628300-71-0, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in oncology. It functions as a selective inhibitor of specific protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth, proliferation, and survival. The compound is characterized by its ability to modulate these pathways, potentially leading to the inhibition of tumor growth and the induction of apoptosis in cancer cells. In terms of its chemical properties, MLN3126 exhibits a defined molecular structure that contributes to its biological activity, although specific details regarding its solubility, stability, and pharmacokinetics would depend on the formulation and context of use. As with many investigational drugs, ongoing research is essential to fully elucidate its efficacy, safety profile, and mechanism of action in clinical settings.

<p>MLN3126: Oral CCR9 blocker, hinders CCL25-triggered chemotaxis/thymocyte calcium influx, IC50 of 6.3 nM.</p>

CAS 628300-71-0

MLN3126

MLN3126

Ref: TM-T62660